FDA inspection
Aurobindo Pharma Limited: FDA inspection ending May 10, 2022
FDA inspection 1169446 · Voluntary Action Indicated (VAI) · Jedcherla Mandal, Mahabubnagar
Key facts
| Inspection ID | 1169446 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3007373532 |
| Address | Unit Vii, Formulation Plant, Plot S-1, Survey 411, 425, 434-435, 458, Tsiic, Green Ind. Park |
| City | Jedcherla Mandal, Mahabubnagar |
| Country | India |
| Fiscal year | 2022 |
| Inspection end date | May 10, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data